Pediatric Acute Lymphoblastic Leukemia: Efficacy and safety of recombinant E. coli-asparaginase in infants (less than one year of age) with acute lymphoblastic leukemia
The pharmacokinetics, pharmacodynamics, efficacy and safety of a new recombinant E. coli-asparaginase preparation were evaluated in infants (
| Published in: | Haematologica |
|---|---|
| Main Authors: | Inge van der Sluis, Anja Möricke, Gabriele Escherich, Arend von Stackelberg, Wolfgang Holter, Thomas Klingebiel, Christian Flotho, Sabine Legien, Wim Tissing, Marc Bierings, Cecile Guimbal-Schmolck, Uwe Pichlmeier, Hans-Jürgen Kühnel, Rob Pieters |
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2013-11-01
|
| Online Access: | https://haematologica.org/article/view/6831 |
Similar Items
Population pharmacokinetics of intravenous Erwinia asparaginase in pediatric acute lymphoblastic leukemia patients
by: Sebastiaan D.T. Sassen, et al.
Published: (2017-03-01)
by: Sebastiaan D.T. Sassen, et al.
Published: (2017-03-01)
Cost-analysis of treatment of childhood acute lymphoblastic leukemia with asparaginase preparations: the impact of expensive chemotherapy
by: Wing H. Tong, et al.
Published: (2013-05-01)
by: Wing H. Tong, et al.
Published: (2013-05-01)
Desensitization protocol should not be used in acute lymphoblastic leukemia patients with silent inactivation of PEGasparaginase
by: Wing H. Tong, et al.
Published: (2014-07-01)
by: Wing H. Tong, et al.
Published: (2014-07-01)
Corrigendum to Acute pancreatitis following L-asparaginase in acute lymphoblastic leukemia
by: Aziza Elouali, et al.
Published: (2023-01-01)
by: Aziza Elouali, et al.
Published: (2023-01-01)
Toxicity of L-asparaginase drugs in acute lymphoblastic leukemia treatment
by: T. T. Valiev
Published: (2023-09-01)
by: T. T. Valiev
Published: (2023-09-01)
Asparaginase-associated pancreatitis during therapy for pediatric acute lymphoblastic leukemia
by: M. Beth McCarville, et al.
Published: (2025-08-01)
by: M. Beth McCarville, et al.
Published: (2025-08-01)
Asparaginase dosing for acute lymphoblastic leukemia: more questions than answers
by: Etan Orgel
Published: (2025-04-01)
by: Etan Orgel
Published: (2025-04-01)
Thrombotic and Hemorrhagic Complications in the Treatment of Acute Lymphoblastic Leukemia with L-Asparaginase
by: GM Galstyan, et al.
Published: (2018-01-01)
by: GM Galstyan, et al.
Published: (2018-01-01)
PB1739: ADVERSE EFFECTS OF ASPARAGINASE IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
by: Wafa Chenbah, et al.
Published: (2023-08-01)
by: Wafa Chenbah, et al.
Published: (2023-08-01)
Differential impact of asparaginase discontinuation on outcomes of children with T‐cell acute lymphoblastic leukemia and T‐cell lymphoblastic lymphoma
by: Hisashi Ishida, et al.
Published: (2024-06-01)
by: Hisashi Ishida, et al.
Published: (2024-06-01)
Risk factors and outcome of asparaginase-associated pancreatitis in pediatric acute lymphoblastic leukemia
by: Seham Hassan, et al.
Published: (2025-06-01)
by: Seham Hassan, et al.
Published: (2025-06-01)
l‑Asparaginase from Solanum lycopersicum as a Nutraceutical for Acute Lymphoblastic Leukemia
by: Sarina P. Khabade, et al.
Published: (2024-01-01)
by: Sarina P. Khabade, et al.
Published: (2024-01-01)
L-asparaginase induced acute pancreatitis in children with acute lymphoblastic leukemia and its impact on outcome
by: Siddhartha Reddy Dodda, et al.
Published: (2024-01-01)
by: Siddhartha Reddy Dodda, et al.
Published: (2024-01-01)
Acute Pancreatitis and Diabetic Ketoacidosis following L-Asparaginase/Prednisone Therapy in Acute Lymphoblastic Leukemia
by: Dania Lizet Quintanilla-Flores, et al.
Published: (2014-01-01)
by: Dania Lizet Quintanilla-Flores, et al.
Published: (2014-01-01)
KMT2A-rearranged acute lymphoblastic leukemia in infants: current progress and challenges
by: Janine Stutterheim, et al.
Published: (2025-04-01)
by: Janine Stutterheim, et al.
Published: (2025-04-01)
Blinatumomab restores asparaginase activity in pediatric B-cell acute lymphoblastic leukemia patients with PEG-Asparaginase hypersensitivity
by: Xue Tang, et al.
Published: (2025-09-01)
by: Xue Tang, et al.
Published: (2025-09-01)
Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study Protocol
by: Carmelo Rizzari, et al.
Published: (2023-06-01)
by: Carmelo Rizzari, et al.
Published: (2023-06-01)
Hypersensitivity Reactions to Native E. coli L-asparaginase in Children With Acute Lymphoblastic Leukemia Treated in Trial ALL-BFM 2000: Impact of Treatment Schedule and Type of Glucocorticoid in Induction
by: Anja Möricke, et al.
Published: (2023-06-01)
by: Anja Möricke, et al.
Published: (2023-06-01)
IGH rearrangements in Down syndrome acute lymphoblastic leukemia
by: Naomi Michels, et al.
Published: (2025-06-01)
by: Naomi Michels, et al.
Published: (2025-06-01)
Changes in asparaginase exposure and toxicity profiles in obese pediatric acute lymphoblastic leukemia patients
by: John C. Panetta, et al.
Published: (2025-02-01)
by: John C. Panetta, et al.
Published: (2025-02-01)
Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance
by: Shih-Hsiang Chen
Published: (2015-10-01)
by: Shih-Hsiang Chen
Published: (2015-10-01)
Preclinical evaluation of engineered L-asparaginase variants to improve the treatment of Acute Lymphoblastic Leukemia
by: Soumika Sengupta, et al.
Published: (2024-05-01)
by: Soumika Sengupta, et al.
Published: (2024-05-01)
Selection of the Optimal L-asparaginase II Against Acute Lymphoblastic Leukemia: An In Silico Approach
by: Adesh Baral, et al.
Published: (2021-09-01)
by: Adesh Baral, et al.
Published: (2021-09-01)
Hypoglycemia associated with L-asparaginase in acute lymphoblastic leukemia treatment: a case report
by: Tanaka Ryuma, et al.
Published: (2012-04-01)
by: Tanaka Ryuma, et al.
Published: (2012-04-01)
Acute lymphoblastic leukemia
by: Martin Schrappe
Published: (2018-06-01)
by: Martin Schrappe
Published: (2018-06-01)
Acute lymphoblastic leukemia
by: Toljić Branka G., et al.
Published: (2023-01-01)
by: Toljić Branka G., et al.
Published: (2023-01-01)
An ensemble-acute lymphoblastic leukemia model for acute lymphoblastic leukemia image classification
by: Mei-Ling Huang, et al.
Published: (2024-01-01)
by: Mei-Ling Huang, et al.
Published: (2024-01-01)
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study
by: Carmelo Rizzari, et al.
Published: (2019-09-01)
by: Carmelo Rizzari, et al.
Published: (2019-09-01)
Monitoring asparaginase activity to improve the management of patients with acute lymphoblastic leukemia: Experience in one center
by: Marina García Morin, et al.
Published: (2024-01-01)
by: Marina García Morin, et al.
Published: (2024-01-01)
L-asparaginase for adult CD20 positive B-cell precursor acute lymphoblastic leukemia
by: Sébastien Maury, et al.
Published: (2010-06-01)
by: Sébastien Maury, et al.
Published: (2010-06-01)
Higher incidence of delayed methotrexate clearance in pediatric acute lymphoblastic leukemia patients treated with imatinib
by: Inge M. van der Sluis, et al.
Published: (2023-12-01)
by: Inge M. van der Sluis, et al.
Published: (2023-12-01)
Acute lymphoblastic leukemia in children
by: M. A. Maschan, et al.
Published: (2022-11-01)
by: M. A. Maschan, et al.
Published: (2022-11-01)
Acute lymphoblastic leukemia and toxoplasmosis
by: G Hiçsönmez, et al.
Published: (1979-01-01)
by: G Hiçsönmez, et al.
Published: (1979-01-01)
Osteoporosis in Acute Lymphoblastic Leukemia
by: Lestry Fibriani, et al.
Published: (2019-09-01)
by: Lestry Fibriani, et al.
Published: (2019-09-01)
Acute lymphoblastic leukemia in infants
by: Aytemiz Gürgey, et al.
Published: (2004-04-01)
by: Aytemiz Gürgey, et al.
Published: (2004-04-01)
Acute Lymphoblastic Leukemia and Seizures
by: J Gordon Millichap
Published: (1995-08-01)
by: J Gordon Millichap
Published: (1995-08-01)
T-cell acute lymphoblastic leukemia
by: Sabina Chiaretti, et al.
Published: (2009-02-01)
by: Sabina Chiaretti, et al.
Published: (2009-02-01)
Pediatric acute lymphoblastic leukemia
by: Hiroto Inaba, et al.
Published: (2020-09-01)
by: Hiroto Inaba, et al.
Published: (2020-09-01)
Immunoglobulin prophylaxis prevents hospital admissions for fever in pediatric acute lymphoblastic leukemia: results of a multicenter randomized trial
by: Kirsten A. Thus, et al.
Published: (2024-08-01)
by: Kirsten A. Thus, et al.
Published: (2024-08-01)
Expert recommendations for pancreatitis/pancreatic necrosis treatment after L-asparaginase in children with acute lymphoblastic leukemia
by: T. T. Valiev, et al.
Published: (2024-04-01)
by: T. T. Valiev, et al.
Published: (2024-04-01)
Similar Items
-
Population pharmacokinetics of intravenous Erwinia asparaginase in pediatric acute lymphoblastic leukemia patients
by: Sebastiaan D.T. Sassen, et al.
Published: (2017-03-01) -
Cost-analysis of treatment of childhood acute lymphoblastic leukemia with asparaginase preparations: the impact of expensive chemotherapy
by: Wing H. Tong, et al.
Published: (2013-05-01) -
Desensitization protocol should not be used in acute lymphoblastic leukemia patients with silent inactivation of PEGasparaginase
by: Wing H. Tong, et al.
Published: (2014-07-01) -
Corrigendum to Acute pancreatitis following L-asparaginase in acute lymphoblastic leukemia
by: Aziza Elouali, et al.
Published: (2023-01-01) -
Toxicity of L-asparaginase drugs in acute lymphoblastic leukemia treatment
by: T. T. Valiev
Published: (2023-09-01)
